GAMMA Investing LLC Buys 698 Shares of Koninklijke Philips (NYSE:PHG)

GAMMA Investing LLC grew its stake in shares of Koninklijke Philips (NYSE:PHGFree Report) by 10.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,148 shares of the technology company’s stock after buying an additional 698 shares during the period. GAMMA Investing LLC’s holdings in Koninklijke Philips were worth $180,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Principal Securities Inc. bought a new stake in Koninklijke Philips during the 4th quarter worth approximately $27,000. Allspring Global Investments Holdings LLC bought a new position in shares of Koninklijke Philips in the first quarter worth $40,000. Fifth Third Bancorp increased its holdings in shares of Koninklijke Philips by 34.4% in the first quarter. Fifth Third Bancorp now owns 3,008 shares of the technology company’s stock worth $60,000 after purchasing an additional 770 shares during the period. Headlands Technologies LLC purchased a new stake in shares of Koninklijke Philips in the first quarter worth $91,000. Finally, 1832 Asset Management L.P. boosted its stake in Koninklijke Philips by 42.6% during the first quarter. 1832 Asset Management L.P. now owns 5,945 shares of the technology company’s stock valued at $119,000 after buying an additional 1,777 shares during the period. 13.67% of the stock is owned by hedge funds and other institutional investors.

Koninklijke Philips Price Performance

NYSE:PHG traded up $0.65 during mid-day trading on Tuesday, reaching $28.68. The stock had a trading volume of 766,203 shares, compared to its average volume of 1,049,779. The stock has a market capitalization of $26.96 billion, a P/E ratio of -29.20, a P/E/G ratio of 0.96 and a beta of 0.72. The firm has a 50 day moving average price of $26.42 and a two-hundred day moving average price of $23.65. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.78 and a current ratio of 1.16. Koninklijke Philips has a one year low of $17.75 and a one year high of $29.53.

Koninklijke Philips Cuts Dividend

The firm also recently disclosed an annual dividend, which was paid on Thursday, May 9th. Stockholders of record on Friday, May 10th were issued a $0.9154 dividend. The ex-dividend date was Thursday, May 9th. This represents a dividend yield of 3.5%. Koninklijke Philips’s payout ratio is -94.79%.

Analyst Ratings Changes

Several analysts have weighed in on the company. BNP Paribas raised Koninklijke Philips from an “underperform” rating to a “neutral” rating in a report on Tuesday, May 7th. JPMorgan Chase & Co. upgraded shares of Koninklijke Philips from an “underweight” rating to a “neutral” rating in a research report on Tuesday, April 30th. Sanford C. Bernstein raised shares of Koninklijke Philips from a “market perform” rating to an “outperform” rating in a report on Monday, May 13th. UBS Group upgraded shares of Koninklijke Philips from a “sell” rating to a “neutral” rating in a research report on Tuesday, April 30th. Finally, StockNews.com upgraded shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a research report on Monday, July 15th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold”.

Read Our Latest Stock Analysis on Koninklijke Philips

About Koninklijke Philips

(Free Report)

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.

Featured Stories

Want to see what other hedge funds are holding PHG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Koninklijke Philips (NYSE:PHGFree Report).

Institutional Ownership by Quarter for Koninklijke Philips (NYSE:PHG)

Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.